Company profile: Braeburn
1.1 - Company Overview
Company description
- Provider of opioid use disorder solutions, including BRIXADI, a weekly and monthly injectable medication for moderate to severe OUD, and an Investigator-Initiated Trials program that supports independent research to advance medical and scientific understanding of its products and related therapeutic areas.
Products and services
- BRIXADI: A clinical-grade weekly and monthly injectable medication engineered for moderate to severe opioid use disorder, enabling scheduled injections to treat OUD across defined dosing intervals
- Investigator-Initiated Trials (IIT) Program: A research-grade program supporting independent studies to advance medical and scientific understanding of Braeburn's products and related therapeutic areas
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Braeburn
Xanodyne
HQ: United States
Website
- Description: Provider of integrated specialty pharmaceutical products, developing and commercializing offerings in women's healthcare and pain management in the United States.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xanodyne company profile →
Avation
HQ: United States
Website
- Description: Provider of wearable tibial neuromodulation systems for treating urinary incontinence and urgency from overactive bladder, delivered via a garment and integrated with a mobile app for therapy management and personalized energy delivery, including an eDiary to track patient activity and progress toward goals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avation company profile →
Probiodrug
HQ: Germany
Website
- Description: Provider of drug discovery and development focused on molecules for the treatment of neuronal and autoimmune diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Probiodrug company profile →
Cybin
HQ: Canada
Website
- Description: Provider of clinical-stage psychedelic-based therapeutics for mental health conditions, including CYB003, a deuterated psilocybin analog for Major Depressive Disorder with positive Phase 2 data, and CYB004, a deuterated DMT molecule aimed at treating Generalized Anxiety Disorder, with a US Phase 2 study expected to begin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cybin company profile →
Openwater
HQ: United States
Website
- Description: Provider of a medical technology system focused on treating diseases at the cellular level.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Openwater company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Braeburn
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Braeburn
2.2 - Growth funds investing in similar companies to Braeburn
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Braeburn
4.2 - Public trading comparable groups for Braeburn
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →